LANTHEUS HOLDINGS, INC. (LNTH) FY2026 YTD Q2 Statement of Cash Flows
2026-01-01 to 2026-06-30
Statement of Cash Flows
2026-01-01 to 2026-06-30
Swipe to see the full flow
Chart details
LANTHEUS HOLDINGS, INC. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026
Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Dec 31, 2025
- 360,826,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- Operating activities
- 217,330,000 US dollars. Net cash provided.
- Net income
- 193,446,000 US dollars
- Accounts payable
- 1,580,000 US dollars
- Unrealized (gain) loss on investment in equity securities
- negative 5,369,000 US dollars
- Amortization of debt-related costs
- 2,230,000 US dollars
- Gain on conversion of Installment Note
- negative 2,525,000 US dollars
- Gain on sale of business, net of transaction costs
- negative 59,527,000 US dollars
- Change in fair value of contingent liabilities
- negative 31,755,000 US dollars
- Long-term income tax payable and other long-term liabilities
- 687,000 US dollars
- Deferred taxes
- 6,256,000 US dollars
- Depreciation, amortization and accretion
- 45,265,000 US dollars
- Adjustment to the fair value of asset retirement obligation
- 0 US dollars
- Inventory
- 5,414,000 US dollars
- Other current and noncurrent assets
- 4,844,000 US dollars
- Accrued expenses and other current and noncurrent liabilities
- 21,015,000 US dollars
- Charges incurred pursuant to acquired in-process research and development
- 0 US dollars
- Other
- negative 3,314,000 US dollars
- Stock-based compensation
- 36,048,000 US dollars
- Inventory adjustments
- 1,991,000 US dollars
- Accounts receivable
- 1,044,000 US dollars
- Investing activities
- 23,963,000 US dollars. Net cash provided.
- Acquisition of in-process research and development
- 0 US dollars
- Acquisition, net of cash acquired - Evergreen Theragnostics
- 0 US dollars
- Acquisition, net of cash acquired - Lantheus Biosciences Ltd
- 312,000 US dollars
- Proceeds from sale of business, net of transaction costs
- 24,212,000 US dollars
- Capital expenditures
- negative 5,561,000 US dollars
- Proceeds from sale of assets
- 5,000,000 US dollars
- Purchases of investment in equity securities
- 0 US dollars
- Financing activities
- negative 7,118,000 US dollars. Net cash used.
- Proceeds from stock option exercises
- 8,553,000 US dollars
- Repurchase of common stock
- 0 US dollars
- Proceeds from employee stock purchase plan
- 2,590,000 US dollars
- Payments of long-term debt and other borrowings
- negative 464,000 US dollars
- Payments for minimum statutory tax withholding related to net share settlement of equity awards
- negative 17,797,000 US dollars
- Operating adjustment reconciliation
- 126,374,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- financing gross reconciliation
- 18,261,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- investing gross reconciliation
- 29,524,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- Exchange-rate effect
- 14,000 US dollars
- Ending cash on Jun 30, 2026
- 595,015,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- Cash sources and uses
- 602,133,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- 234,189,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- 1.12×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Chart connections
- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $23.88M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!